2016
DOI: 10.1128/aac.02242-15
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Pseudomonas aeruginosa ExsA DNA-Binding Activity by N -Hydroxybenzimidazoles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
20
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 43 publications
0
20
0
Order By: Relevance
“…N-hydroxybenzimidazole-binding pocket is located in the ExsA DNA-binding domain. Specific amino acid substitutions in this pocket resulted in altered sensitivity to N-hydroxybenzimidazoles, which enabled researchers to determine putative ligand-binding sites and helped designing higher-affinity inhibitors [48]. The interaction between N-hydroxybenzimidazoles and ExsA seems to be specific, because no effect has been observed on the binding to DNA of other virulence regulators, such as Vfr.…”
Section: Pathogenicity Related To the T3ssmentioning
confidence: 98%
See 1 more Smart Citation
“…N-hydroxybenzimidazole-binding pocket is located in the ExsA DNA-binding domain. Specific amino acid substitutions in this pocket resulted in altered sensitivity to N-hydroxybenzimidazoles, which enabled researchers to determine putative ligand-binding sites and helped designing higher-affinity inhibitors [48]. The interaction between N-hydroxybenzimidazoles and ExsA seems to be specific, because no effect has been observed on the binding to DNA of other virulence regulators, such as Vfr.…”
Section: Pathogenicity Related To the T3ssmentioning
confidence: 98%
“…N-hydroxybenzimidazoles interact with the carboxy-terminal domain of ExsA, preventing its binding to promoter sites on DNA [47,48]. N-hydroxybenzimidazole-binding pocket is located in the ExsA DNA-binding domain.…”
Section: Pathogenicity Related To the T3ssmentioning
confidence: 99%
“…Several N-hydroxybenzimidazoles with 50% inhibitory concentrations (IC 50 s) in the low-micromolar range inhibit the DNA-binding activity of ExsA in vitro and T3SS-dependent toxicity toward macrophages (179). The N-hydroxybenzimidazoles interact with the carboxy-terminal DNA-binding domain of ExsA to inhibit DNA-binding activity (180). N-Hydroxybenzimidazoles also inhibit the DNA-binding activity of ExsA orthologs from Yersinia pestis, Aeromonas hydrophila, Photorhabdus luminescens, and Vibrio parahaemolyticus (180).…”
Section: Therapeutics and Inhibitors Of T3ss Gene Expressionmentioning
confidence: 99%
“…The N-hydroxybenzimidazoles interact with the carboxy-terminal DNA-binding domain of ExsA to inhibit DNA-binding activity (180). N-Hydroxybenzimidazoles also inhibit the DNA-binding activity of ExsA orthologs from Yersinia pestis, Aeromonas hydrophila, Photorhabdus luminescens, and Vibrio parahaemolyticus (180). Although active against ExsA in vitro, N-hydroxybenzimidazoles do not inhibit ExsA-dependent promoter activity in vivo when using either P. aeruginosa or E. coli reporter strains.…”
Section: Therapeutics and Inhibitors Of T3ss Gene Expressionmentioning
confidence: 99%
“…In the case of ExsA it is regulated through protein-protein contacts rather than small molecules. The inhibitors of DBD of ExsA belong to N-Hydroxybenzimidazole [14]. As mentioned above the DBD of these two proteins contain HTH motif, so there could be a common mechanism.…”
Section: Introductionmentioning
confidence: 99%